Transmission of human herpesvirus-8 through liver transplantation and development of post-transplantation Kaposi sarcoma: A case report
Even in low-prevalence areas, there are benefits of targeted screening for HHV-8 in high-risk organ donors and recipients described in the literature and highlighted in the current case. Post-transplantation Kaposi sarcoma due to HHV-8 may be managed with reduction in immunosuppressive treatment and conversion from calcineurin inhibitors to mTOR inhibitors.
Authors
- J. Clemmesen
- Nicoline Stender Arentoft (ORCID: https://orcid.org/0000-0001-9083-863X)
- Sanne Schnell Nielsen (ORCID: https://orcid.org/0000-0002-9981-8288)
- Nikolai Kirkby (ORCID: https://orcid.org/0000-0001-7498-2738)
- Michael Perch (ORCID: https://orcid.org/0000-0001-9740-1246)
- Moises Alberto Suarez‐Zdunek (ORCID: https://orcid.org/0000-0003-0772-1049)
- Gro Linno Willemoe (ORCID: https://orcid.org/0000-0002-9886-7299)
- Christian Ross Pedersen
- Jens Hillingsø
- Annika Loft
- Nicolai Aagaard Schultz (ORCID: https://orcid.org/0000-0002-3097-2690)
Institutions
- University of Copenhagen (DK)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
Publication Details
- Journal
- IDCases
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.idcr.2025.e02263
- Citations
- 2
- Primary Topic
- Viral-associated cancers and disorders
- Type
- article
- Field-Weighted Citation Impact
- 2.09